Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.980
+0.020 (1.02%)
At close: Sep 29, 2026, 4:00 PM EDT
2.010
+0.030 (1.52%)
Pre-market: Sep 30, 2026, 4:00 AM EDT
Pulmonx Revenue
Pulmonx had revenue of $22.76M in the quarter ending June 30, 2026, a decrease of -4.62%. This brings the company's revenue in the last twelve months to $87.44M, down -3.43% year-over-year. In the year 2025, Pulmonx had annual revenue of $90.50M with 8.01% growth.
Revenue (ttm)
$87.44M
Revenue Growth
-3.43%
P/S Ratio
0.97
Revenue / Employee
$295,412
Employees
296
Market Cap
85.04M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 90.50M | 6.71M | 8.01% |
| Dec 31, 2024 | 83.79M | 15.11M | 22.01% |
| Dec 31, 2023 | 68.68M | 15.01M | 27.98% |
| Dec 31, 2022 | 53.66M | 5.25M | 10.84% |
| Dec 31, 2021 | 48.42M | 15.68M | 47.91% |
| Dec 31, 2020 | 32.73M | 138.00K | 0.42% |
| Dec 31, 2019 | 32.60M | 12.59M | 62.94% |
| Dec 31, 2018 | 20.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Outset Medical | 117.80M |
| TELA Bio | 79.91M |
| CVRx, Inc. | 61.19M |
| LENSAR | 60.26M |
| Apyx Medical | 58.42M |
| Myomo | 43.26M |
| electroCore | 36.97M |
| MaxCyte | 31.05M |
LUNG News
- 4 weeks ago - Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Pulmonx to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Pulmonx management to meet virtually with Lake Street - TheFly
- 7 weeks ago - Pulmonx Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 2 months ago - Pulmonx reports Q2 EPS (24c), consensus (28c) - TheFly
- 2 months ago - Pulmonx backs FY26 revenue view $90M-$92M, consensus $90.77M - TheFly
- 2 months ago - Pulmonx Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - Pulmonx Earnings release: Q2 2026 - Filings